Akademisyen
NESLİHAN DEMİREL ÖĞÜT
DOÇENT
UŞAK ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Deri ve Zührevi Hastalıkları
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 44
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
17
Q2
19
Q3
3
Q4
8
WoS (JCR)
Q1
13
Q2
13
Q3
11
Q4
7
TR Index
12
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
6
Ort. yüzdelik
62.6%
Üst %1 payı
0.0%
Üst %10 payı
12.2%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Evaluation of Factors Associated with a History of Skin Cancer in Patients with Actinic Keratosis: AKASI as a Clinical Tool for Risk Stratification YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 10.1%
- 2026 Evaluation of the Relationship Between Clinical Features of Acrochordons and Metabolic Syndrome Components: Prospective Cross-Sectional Study YÖKSİS TR Index SJR Q4 OpenAlex 28.2%
- 2025 Dysmenorrhea in Chronic Spontaneous Urticaria: A Subset of Patients Report Worsening and Partial Antihistamine Benefit: UCARE HURDLE ‐I Study YÖKSİS SJR Q1 JCR Q1 OpenAlex 60.9%
- 2025 Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study YÖKSİS SJR Q1 JCR Q1 OpenAlex 76.9%
- 2025 Dermatologists Way of Informative Content About Dermatology and Cosmetology on Social Media YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.6%
- 2025 New-Onset Pyoderma Gangrenosum in a Patient with Moderateto-Severe Plaque Psoriasis on Ixekizumab Treatment: A Case Report and Review of the Literature YÖKSİS TR Index SJR Q4 OpenAlex üst %10 OpenAlex 90.7%
- 2025 Predictive factors for early super response to bimekizumab in 341 patients with psoriasis-a 24-week short-term multicenter real-life experience YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.6%
- 2024 A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis YÖKSİS SJR Q1 JCR Q1 OpenAlex 48.6%
- 2024 No association between isotretinoin and impulsivity in patients with moderate‐to‐severe acne vulgaris YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.3%
- 2023 Impulsivity in patients with acne excoriee YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.0%
- 2023 Two paradoxical reactions in a patient with psoriasis and psoriatic arthritis: Adalimumab‐induced hidradenitis suppurativa and secukinumab‐induced alopecia areata YÖKSİS SJR Q1 JCR Q1 OpenAlex 70.7%
- 2023 Scabies Affects Quality of Life in Correlation with Depression and Anxiety YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.1%
- 2023 Evaluation of skin disease patterns in a tertiary dermatology outpatient clinic in Türkiye YÖKSİS TR Index OpenAlex 15.2%
- 2023 The effect of systemic therapies on hemogram parameters and C-reactive protein in patients with psoriatic arthritis YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 62.0%
- 2022 Trichotillomania, Skin Picking Disorder, and Different Aspects of Impulsivity: A Systematic Review YÖKSİS SJR Q4 JCR Q4 OpenAlex 33.3%
- 2022 Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID‐19 pandemic YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.5%
- 2022 Possible ruxolitinib‐induced acquired epidermodysplasia verruciformis and multiple non‐melanoma skin cancers in a patient with polycythemia vera YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.9%
- 2022 Alterations of the human gut microbiome in patients with hidradenitis suppurativa: a case-control study and review of the literature YÖKSİS SJR Q3 JCR Q2 OpenAlex 87.4%
- 2022 A real life experience with ustekinumab: The effectiveness of 45 mg on patients greater than 80 kg but lower than 100 kg YÖKSİS SJR Q1 JCR Q1 OpenAlex 2.6%
- 2022 Acquired plantar port‐wine stain (Fegeler syndrome) following prolonged standing YÖKSİS SJR Q2 JCR Q3 OpenAlex 57.4%